NRAS and myeloid sarcoma: Among them, NRAS (Fig. 9A, AUC = 0.637), KLF2 (Fig. 9B, AUC = 0.626), VDAC3 (Fig. 9C, AUC = 0.622), ATM (Fig. 9D, AUC = 0.617), PIK3CA (Fig. 9E, AUC = 0.614), MAPK1 (Fig. 9F, AUC = 0.607), and PCBP1 (Fig. 9G, AUC = 0.606) showed low diagnostic accuracy in distinguishing MS and Normal groups.